We are live on
!
Find out more
BM
Brandywine Managers Portfolio holdings
AUM
$170M
1-Year Est. Return
10.01%
This Fund
S&P 500
This Quarter
Est. Return
-3.74%
1 Year Est. Return
+10.01%
3 Year Est. Return
+53.1%
5 Year Est. Return
+7.42%
10 Year Est. Return
+248.69%
AUM
$83.4M
AUM Growth
-$11.5M
(-12%)
Cap. Flow
-$7.08M
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
83.19%
Holding
37
New
–
Increased
2
Reduced
6
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MongoDB
MDB
|
+$156K |
| 2 |
10x Genomics
TXG
|
+$112K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$6.23M |
| 2 |
Viking Therapeutics
VKTX
|
+$325K |
| 3 |
Mobileye
MBLY
|
+$260K |
| 4 |
Okta
OKTA
|
+$154K |
| 5 |
Veeva Systems
VEEV
|
+$151K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 46.26% |
| 2 | Healthcare | 11.56% |
| 3 | Financials | 1.17% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
SentinelOne
S
$6.71B
| $345K | 0.41% |
19,001
| – | – |
|
|
NVO
27
Novo Nordisk
NVO
$223B
| $293K | 0.35% |
4,222
| – | – |
|
28
Moderna
MRNA
$24.5B
| $270K | 0.32% |
9,510
| – | – |
|
29
Klaviyo
KVYO
$5.29B
| $263K | 0.32% |
8,692
| – | – |
|
30
Twilio
TWLO
$31.4B
| $231K | 0.28% |
2,357
| – | – |
|
31
Beam Therapeutics
BEAM
$2.83B
| $221K | 0.26% |
11,306
| – | – |
|
32
Structure Therapeutics
GPCR
$3.45B
| $191K | 0.23% |
11,057
| – | – |
|
|
33
10x Genomics
TXG
$5.55B
| $165K | 0.2% |
18,938
+8,865
| +88% | +$112K |
|
34
Relay Therapeutics
RLAY
$4.34B
| $101K | 0.12% |
38,429
| – | – |
|
35
AbCellera Biologics
ABCL
$1.97B
| $63.5K | 0.08% |
28,488
| – | – |
|
|
36
Mobileye
MBLY
$7.76B
| – | – |
-13,067
| Closed | -$260K |
|
|
37
Viking Therapeutics
VKTX
$4.31B
| – | – |
-8,082
| Closed | -$325K |
|
Similar funds
CF
DBFM
CAS
FH
RWFS
RFO
DWM
AGC
Brandywine Managers's Q1 2025 Portfolio in Review
As of Q1 2025, Brandywine Managers held 37 positions worth $83.4M, down 12% from $94.9M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Brandywine Managers withdrew a net $7.08M in Q1 2025, closing 2 positions and reducing 6 holdings. Its most notable exit was Viking Therapeutics, an estimated $325K position sold in full.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 45% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Brandywine Managers added an estimated $156K to MongoDB.
- Brandywine Managers added most to MongoDB in Q1 2025, an estimated $156K increase.
- Brandywine Managers's biggest Q1 2025 reduction was iShares MSCI ACWI ETF, cutting an estimated $6.23M.
- Brandywine Managers fully exited Viking Therapeutics in Q1 2025, selling an estimated $325K.
- Brandywine Managers's ten largest holdings make up 83% of its $83.4M portfolio in Q1 2025.
- Brandywine Managers opened 0 new positions and closed 2 in Q1 2025.
- Brandywine Managers's portfolio value fell 12% quarter-over-quarter to $83.4M.
Based on Brandywine Managers's 13F filing for Q1 2025, filed 15 May 2025.